What about incorporating selenium in the therapeutic regimen of SARS-CoV-2?

dc.contributor.authorBenarba, Bachir
dc.contributor.authorPandiella, Atanasio
dc.date.accessioned2020-12-18T11:17:17Z
dc.date.available2020-12-18T11:17:17Z
dc.date.issued2020-12-07
dc.identifier.citationBenarba, B., & Pandiella, A. (2020). What about incorporating selenium in the therapeutic regimen of SARS-CoV-2?. EXCLI Journal, 19, 1544-1546. https://doi.org/10.17179/excli2020-2968en
dc.identifier.issn1611-2156
dc.identifier.urihttp://hdl.handle.net/2003/39936
dc.identifier.urihttp://dx.doi.org/10.17877/DE290R-21826
dc.language.isoen
dc.publisherIfADo - Leibniz Research Centre for Working Environment and Human Factors, Dortmunden
dc.relation.ispartofseriesEXCLI Journal;Vol. 19 2020
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectCOVID-19en
dc.subjectSeleniumen
dc.subjectSARS-CoV-2en
dc.subject.ddc610
dc.titleWhat about incorporating selenium in the therapeutic regimen of SARS-CoV-2?en
dc.typeText
dc.type.publicationtypearticle
dcterms.accessRightsopen access
eldorado.dnb.zdberstkatid2132560-1
eldorado.identifier.urlhttps://www.excli.de/index.php/excli/article/view/2968
eldorado.secondarypublicationtrue

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
excli2020-2968.pdf
Size:
556.04 KB
Format:
Adobe Portable Document Format
Description:
DNB
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
4.85 KB
Format:
Item-specific license agreed upon to submission
Description: